Detecting familial hypercholesterolaemia in the community: impact of a telephone call from a chemical pathologist to the requesting general practitioner

Atherosclerosis. 2014 Jun;234(2):469-72. doi: 10.1016/j.atherosclerosis.2014.04.002. Epub 2014 Apr 14.

Abstract

Objective: To determine whether a telephone call from a chemical pathologist to the requesting general practitioner (GP) of individuals at high risk of familial hypercholesterolaemia (FH) increases specialist referral and detection of FH.

Method: Individuals with an LDL-cholesterol ≥ 6.5 mmol/L without secondary causes were identified from a community laboratory; 100 cases and 96 historical controls. All laboratory reports (cases and controls) received interpretative comments highlighting FH. In addition, the cases' GPs received a telephone call from the chemical pathologist to highlight their patient's risk of FH and suggest specialist referral, whereas with the controls' GPs were not telephoned.

Results: After 12 months follow-up, 27 (27%) cases were referred to clinic compared with 4 (4%) controls (p < 0.0001). 25 cases were reviewed at clinic, 12 (48%) had definite FH and 18 (72%) had probable or definite FH according to the Dutch Lipid Clinic Network Criteria, 2 cases did not attend their clinic appointments. Genetic testing was performed in 23 individuals: 7 (30%) had pathogenic FH mutations. Genotypic cascade screening of 4 kindreds from the intervention group detected an additional 7 individuals with FH and excluded 5 mutation-negative family members.

Conclusions: A telephone call from a chemical pathologist to the requesting GP of patients at high risk of FH was associated with significantly higher rates of FH detection and specialist referral. Over 70% of individuals with an LDL-cholesterol ≥ 6.5 mmol/L were diagnosed with FH. However, further investigation is required to improve the relatively low referral rate.

Keywords: Community laboratory; Detection; Familial hypercholesterolaemia; Opportunistic screening.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Attitude of Health Personnel
  • Biomarkers / blood
  • Case-Control Studies
  • Cholesterol, LDL / blood*
  • Community Health Services*
  • Female
  • General Practitioners*
  • Genetic Predisposition to Disease
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Hyperlipoproteinemia Type II / blood
  • Hyperlipoproteinemia Type II / diagnosis*
  • Hyperlipoproteinemia Type II / genetics
  • Interdisciplinary Communication*
  • Male
  • Middle Aged
  • Pathology, Clinical*
  • Phenotype
  • Predictive Value of Tests
  • Referral and Consultation
  • Risk Assessment
  • Risk Factors
  • Telephone*
  • Up-Regulation
  • Western Australia
  • Young Adult

Substances

  • Biomarkers
  • Cholesterol, LDL